1.
Mark Bosch, Ariz Akhter, Bingshu E. Chen, Adnan Mansoor, David Lebrun, David Good, Michael Crump, Lois Shepherd, David W. Scott, Douglas A. Stewart. A bioclinical prognostic model using MYC and BCL2 predicts outcome in relapsed/refractory diffuse large B-cell lymphoma. Haematologica 2018;103(2):288-296; https://doi.org/10.3324/haematol.2017.179309.